Advanced

Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population

Chaste, Pauline; Clement, Nathalie; Mercati, Oriane; Guillaume, Jean-Luc; Delorme, Richard; Goubran-Botros, Hany; Pagan, Cécile; Périvier, Samuel; Scheid, Isabelle and Nygren, Gudrun, et al. (2010) In PLoS ONE 5(7). p.1-11
Abstract
Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatonin-related receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The... (More)
Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatonin-related receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD (MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls). Concerning GPR50, we detected a significant association between ASD and two variations, Delta502-505 and T532A, in affected males, but it did not hold up after Bonferonni correction for multiple testing. Our results represent the first functional ascertainment of melatonin receptors in humans and constitute a basis for future structure-function studies and for interpreting genetic data on the melatonin pathway in patients. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
PLoS ONE
volume
5
issue
7
pages
1 - 11
publisher
Public Library of Science
external identifiers
  • wos:000279924500002
  • scopus:77955389706
DOI
10.1371/journal.pone.0011495
language
English
LU publication?
yes
id
9da38e27-526f-4b73-8a4a-78e829215223 (old id 1600592)
date added to LUP
2012-01-19 11:34:41
date last changed
2017-05-28 04:41:42
@article{9da38e27-526f-4b73-8a4a-78e829215223,
  abstract     = {Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatonin-related receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD (MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls). Concerning GPR50, we detected a significant association between ASD and two variations, Delta502-505 and T532A, in affected males, but it did not hold up after Bonferonni correction for multiple testing. Our results represent the first functional ascertainment of melatonin receptors in humans and constitute a basis for future structure-function studies and for interpreting genetic data on the melatonin pathway in patients.},
  author       = {Chaste, Pauline and Clement, Nathalie and Mercati, Oriane and Guillaume, Jean-Luc and Delorme, Richard and Goubran-Botros, Hany and Pagan, Cécile and Périvier, Samuel and Scheid, Isabelle and Nygren, Gudrun and Anckarsäter, Henrik and Råstam, Maria and Ståhlberg, Ola and Gillberg, Carina and Serrano, Emilie and Lemière, Nathalie and Launay, Jean-Marie and Mouren-Simeoni, Marie-Christine and Leboyer, Marion and Gillberg, Christopher and Jockers, Ralf and Thomas, Bourgeron},
  language     = {eng},
  number       = {7},
  pages        = {1--11},
  publisher    = {Public Library of Science},
  series       = {PLoS ONE},
  title        = {Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population},
  url          = {http://dx.doi.org/10.1371/journal.pone.0011495},
  volume       = {5},
  year         = {2010},
}